Treatment of Fatty Liver Disease with Unani Medicine
- Conditions
- Health Condition 1: K77- Liver disorders in diseases classified elsewhere
- Registration Number
- CTRI/2024/04/065391
- Lead Sponsor
- Jamia Hamdard
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients of grade 1 and grade 2 Fatty Liver (up-to 290 db/m in QUS/ Fibroscan)
2. Patients willing to participate and ready to sign the written informed consent.
3. Patients diagnosed as having fatty liver based on the ultrasonography report.
4. Patients with/ without clinical signs and symptoms.
1. Patients having documented fatty liver grade 3 or above.
2. Use of alcohol or any other drug abuse.
3. Patients diagnosed with any coexisting liver disease.
4. Pregnant and lactating women.
5. Patients suffering with Hypertension, CKD, CAD, CLD or uncontrolled DM, Hypothyroidism.
6. Patient having immune-compromised status.
7. Patient using lipid lowering drugs or dietary supplements within the last 3 weeks.
8. Oral contraceptives & corticosteroids.
9. Neurological disorders like epilepsy or psychiatric disorders.
10. Patient having history of Pancreatitis.
11. Acute hepatitis with raised serum bilirubin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Fatty liver grade assessed by QUS.Timepoint: 1st day and 90th day
- Secondary Outcome Measures
Name Time Method Improvement in Liver Function Test, <br/ ><br>Improvement in Lipid profileTimepoint: 1st day and 90th day